Note*: This report requires 7-10 business days to complete.
DelveInsight’s Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Heart Failure forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chronic Heart Failure till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Heart Failure market.
• Identifying patient populations in the global “Chronic Heart Failuremarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Chronic Heart Failure therapeutics in each of the markets covered.
• To understand the future market competition in the global Chronic Heart Failure therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Chronic Heart Failure for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Chronic Heart Failure overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Chronic Heart Failure Market
• Global Epidemiology of Chronic Heart Failure Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Chronic Heart Failure Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Chronic Heart Failure (2013-2023)
• Table 7: Chronic Heart Failure Global Market (USD Millions), (2013-2015)
• Table 8: Chronic Heart Failure Global Market (USD Millions), (2016-2023)
• Table 9: Chronic Heart Failure US Market (USD Millions), (2013-2015)
• Table 10: Chronic Heart Failure US Market (USD Millions), (2016-2023)
• Table 11: Chronic Heart Failure Germany Market (USD Millions), (2013-2015)
• Table 12: Chronic Heart Failure Germany Market (USD Millions), (2016-2023)
• Table 13: Chronic Heart Failure United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Chronic Heart Failure United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Chronic Heart Failure France Market (USD Millions), (2013-2015)
• Table 16: Chronic Heart Failure France Market (USD Millions), (2016-2023)
• Table 17: Chronic Heart Failure Italy Market (USD Millions), (2013-2015)
• Table 18: Chronic Heart Failure Italy Market (USD Millions), (2016-2023)
• Table 19: Chronic Heart Failure Spain Market (USD Millions), (2013-2015)
• Table 20: Chronic Heart Failure Spain Market (USD Millions), (2016-2023)
• Table 21: Chronic Heart Failure Japan Market (USD Millions), (2013-2015)
• Table 22: Chronic Heart Failure Japan Market (USD Millions), (2016-2023)
• Table 23: Chronic Heart Failure ROW Market (USD Millions), (2013-2015)
• Table 24: Chronic Heart Failure ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Chronic Heart Failure Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Chronic Heart Failure (2013-2023)
• Figure 3: Chronic Heart Failure Global Market (USD Millions), (2013-2015)
• Figure 4: Chronic Heart Failure Global Market (USD Millions), (2016-2023)
• Figure 5: Chronic Heart Failure US Market (USD Millions), (2013-2015)
• Figure 6: Chronic Heart Failure US Market (USD Millions), (2016-2023)
• Figure 7: Chronic Heart Failure Germany Market (USD Millions), (2013-2015)
• Figure 8: Chronic Heart Failure Germany Market (USD Millions), (2016-2023)
• Figure 9: Chronic Heart Failure United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Chronic Heart Failure United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Chronic Heart Failure France Market (USD Millions), (2013-2015)
• Figure 12: Chronic Heart Failure France Market (USD Millions), (2016-2023)
• Figure 13: Chronic Heart Failure Italy Market (USD Millions), (2013-2015)
• Figure 14: Chronic Heart Failure Italy Market (USD Millions), (2016-2023)
• Figure 15: Chronic Heart Failure Spain Market (USD Millions), (2013-2015)
• Figure 16: Chronic Heart Failure Spain Market (USD Millions), (2016-2023)
• Figure 17: Chronic Heart Failure Japan Market (USD Millions), (2013-2015)
• Figure 18: Chronic Heart Failure Japan Market (USD Millions), (2015-2023)
• Figure 19: Chronic Heart Failure ROW Market (USD Millions), (2013-2015)
• Figure 20: Chronic Heart Failure ROW Market (USD Millions), (2016-2023)
• Amgen Inc.
• AnGes MG Inc.
• Bayer AG
• Capricor Therapeutics Inc.
• Celyad SA
• Juventas Therapeutics Inc.
• Laboratoires Pierre Fabre SA
• Les Laboratoires Servier SAS
• Mast Therapeutics Inc.
• Mesoblast Limited
• Novartis AG
• Pfizer Inc.
• PhaseBio Pharmaceuticals Inc.
• Sanofi
• Stemedica Cell Technologies Inc.
• Vichem Chemie Research Ltd.
• Zensun (Shanghai) Sci & Tech Co. Ltd.
